Compare MRKR & EFOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRKR | EFOI |
|---|---|---|
| Founded | 1999 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building Products |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.5M | 21.0M |
| IPO Year | 2010 | 2004 |
| Metric | MRKR | EFOI |
|---|---|---|
| Price | $0.95 | $3.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $7.87 | N/A |
| AVG Volume (30 Days) | ★ 60.0K | 10.4K |
| Earning Date | 11-12-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 33.61 | ★ 43.75 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $3,560,000.00 |
| Revenue This Year | $19.61 | $1,341.40 |
| Revenue Next Year | $375.85 | $27.88 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.84 | $1.66 |
| 52 Week High | $2.46 | $9.84 |
| Indicator | MRKR | EFOI |
|---|---|---|
| Relative Strength Index (RSI) | 31.50 | 61.62 |
| Support Level | N/A | $2.78 |
| Resistance Level | $1.31 | $3.34 |
| Average True Range (ATR) | 0.07 | 0.15 |
| MACD | -0.02 | 0.06 |
| Stochastic Oscillator | 5.58 | 59.75 |
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from MAR-T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells. These T cells are designed to recognize multiple tumor targets to produce broad spectrum anti-tumor activity. Its pipeline products include: Autologous MAR-T cell product for the treatment of lymphoma and pancreatic cancer (MT-601), and Off-the-Shelf (OTS) products (MT-401-OTS).
Energy Focus Inc specializes in designing, developing, manufacturing, and selling energy-efficient lighting systems and controls. It provides LED lighting solutions for both commercial and military maritime markets (MMM). Its core products include robust lighting fixtures and lamps for navy and military applications, Energy Storage Systems (ESS), Uninterruptible Power Supply (UPS), and tubular LED (TLED) lighting products, including battery backup units as well as general commercial and maritime lighting fixtures. The company operates in a single business segment that includes the marketing and sale of commercial and MMM lighting products and controls. The company generates a majority of its revenue from the sales of military maritime products in the United States.